DPP4 inhibitor for post-stroke cognitive decline in diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether a type 2 diabetes medicine called a DPP4 inhibitor can help prevent memory and thinking problems after a mild stroke. It is for people with recent stroke and well-controlled diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a mild ischemic stroke within the last 2 weeks
- You have type 2 diabetes that was diagnosed less than 5 years ago
- Your blood sugar control (HbA1c) is between 6.5% and 8.5%
- You are between 40 and 75 years old
- You have at least 9 years of education
- You are not currently taking any DPP4 inhibitors or insulin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.
This study tests if adding a GLP-1 receptor agonist (a type of diabetes medicine that also helps blood vessels) to standard clot removal can improve recovery after a severe stroke. It is for people who had a clot removal for a large artery blockage and can start the drug within 6 hours.
This trial tests whether sodium oligomannate can help prevent or lessen memory and thinking problems that can happen after a first stroke. It may help people who are recently hospitalized for ischemic stroke and have mild cognitive decline risk.
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
This trial tests if tirzepatide, a diabetes drug, can improve recovery in people who had a stroke from a blocked large artery in the brain and then had the clot removed. It may help by reducing inflammation and improving blood sugar control.
This trial tests whether an SGLT2 inhibitor (a diabetes medicine) can protect the brain after a recent moderate-to-severe ischemic stroke. It may help reduce damage and improve recovery.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.